Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: maize starch; microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; iron oxide red; maize starch; microcrystalline cellulose; iron oxide yellow; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: maize starch; crospovidone; magnesium stearate; colloidal anhydrous silica; iron oxide yellow; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; iron oxide yellow; iron oxide red; macrogol 4000; titanium dioxide; hypromellose; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; iron oxide yellow; calcium hydrogen phosphate; colloidal anhydrous silica; pregelatinised maize starch; hypromellose; lactose monohydrate; macrogol 4000; titanium dioxide - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bisoprolol fumarate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; macrogol 4000; lactose monohydrate - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiodarone hydrochloride, quantity: 100 mg - tablet, uncoated - excipient ingredients: crospovidone; microcrystalline cellulose; purified talc; povidone; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - severe cases of tachyarrhythmias (e.g. wolff-parkinson-white syndrome; supraventricular, nodal and ventricular tachycardias; atrial flutter and fibrillation; ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (e.g. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiodarone hydrochloride, quantity: 200 mg - tablet, uncoated - excipient ingredients: povidone; lactose monohydrate; purified talc; microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica - severe cases of tachyarrhythmias (e.g. wolff-parkinson-white syndrome; supraventricular, nodal and ventricular tachycardias; atrial flutter and fibrillation; ventricular fibrillation) not responding to other therapy. treatment should be initiated in hospital. it is recommended that the patient should be regularly monitored for possible toxicity (e.g. thyroid function, chest x-ray, ophthalmological examination, liver function etc.) during the entire course of therapy and for several months after discontinuation.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bisoprolol fumarate, quantity: 10 mg - tablet - excipient ingredients: crospovidone; lactose monohydrate; magnesium stearate; microcrystalline cellulose; iron oxide yellow; iron oxide red - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors and diuretics and, optionally, cardiac glycosides.